Table 1 Age Distribution of 6845 women with HPV E6/E7 mRNA test positivity and NILM cytology
From: Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
≤ 30years | 31-40years | 41-50years | 51-60years | >60years | |
|---|---|---|---|---|---|
Number E6/E7mRNA+ | 1176 | 2189 | 2035 | 1175 | 270 |
(% of age group; 95% CI) | 17.2%(16.3–18.1%) | 32.0%(3.1–3.3%) | 29.7%(28.6–30.8%) | 17.2%(16.3–18.1%) | 3.94%(3.5–4.4%) |
Number Other-hrHPV+ | 633 | 1369 | 1326 | 786 | 174 |
(% of age group; 95% CI) | 9.25%(8.6–9.9%) | 20.0%(19.1–20.9%) | 19.4%(18.4–20.3%) | 11.5%(10.7–12.2%) | 2.5%(2.2–2.9%) |
Number HPV16/18/45+ | 543 | 820 | 709 | 389 | 96 |
(% of age group; 95% CI) | 7.9%(7.3–8.6%) | 12.0%(11.2–12.7%) | 10.4%(9.6–11.1%) | 5.7%(5.1–6.2%) | 1.4%(1.1–1.7%) |
Number HPV16+ | 425 | 603 | 540 | 297 | 77 |
(% of age group; 95% CI) | 6.2%(5.6–6.8%) | 8.8%(8.1–9.5%) | 7.9%(7.3–8.5%) | 4.3%(3.9–4.8%) | 1.1%(0.9–1.4%) |
Number HPV18/45+ | 109 | 197 | 155 | 82 | 18 |
(% of age group; 95% CI) | 1.6%(1.3–1.9%) | 2.9%(2.5–3.3%) | 2.3%(1.9–2.6%) | 1.2%(0.9–1.5%) | 0.3%(0.1–0.4%) |
Number HPV16+/18/45+ | 9 | 20 | 14 | 10 | 1 |
(% of age group; 95% CI) | 0.1%(0.0-0.2%) | 0.3%(0.2–0.4%) | 0.2%(0.1–0.3%) | 0.1%(0.1–0.2%) | 0.0%(0.0–0.0%) |